Walt Addison Linscott - 26 Jan 2022 Form 4 Insider Report for Indaptus Therapeutics, Inc. (INDP)

Role
Chief Business Officer
Signature
/s/ Walt Linscott
Issuer symbol
INDP
Transactions as of
26 Jan 2022
Net transactions value
$0
Form type
4
Filing time
28 Jan 2022, 15:30:25 UTC
Previous filing
06 Aug 2021
Next filing
09 Sep 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INDP Stock Option (right to buy) Award $0 +45,850 $0.000000 45,850 26 Jan 2022 Common Stock 45,850 $4.90 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests and becomes exercisable as to one-third of the total shares on January 26, 2023 and thereafter the remaining shares vest and become exercisable in equal quarterly installments over the following 24 months.